The landscape of pharmaceutical manufacturing is constantly evolving, driven by the need for more effective and targeted therapies. Central to this progress are specialized chemical intermediates that enable the precise construction of complex drug molecules. N-6-Trifluoroacetyl-L-lysine, known by its CAS number 10009-20-8, stands as a prime example of such a pivotal compound.

As a highly valued pharmaceutical intermediate, N-6-Trifluoroacetyl-L-lysine is indispensable in the synthesis of advanced pharmaceutical agents. Its well-defined chemical structure, presented as a white crystalline powder pharmaceutical intermediate, ensures high purity and reliability. This makes it a preferred choice for critical steps in the manufacturing of drugs like lisinopril, where quality and consistency are non-negotiable. The compound's role as a lisinopril synthesis intermediate is a testament to its efficacy and suitability for demanding applications.

Beyond its direct pharmaceutical applications, N-6-Trifluoroacetyl-L-lysine is also a versatile component in broader organic chemical synthesis. Its unique trifluoroacetyl modification on the lysine amino acid chain offers chemists a reactive handle for building complex organic structures. This adaptability makes it a valuable tool for researchers exploring new molecular pathways and developing innovative chemical compounds.

For industries relying on this compound, the assurance of quality from a trusted CAS 10009-20-8 chemical supplier is paramount. When seeking trifluoroacetyllysine for sale, partnering with suppliers who prioritize stringent quality control and consistent supply chains is essential for uninterrupted production and research activities.

The compound’s contribution to the development of both established pharmaceuticals and novel chemical entities highlights its significance in the modern scientific arena. Its role as a lynchpin in advanced intermediate synthesis underscores its importance for progress in medicinal chemistry and beyond.

In conclusion, N-6-Trifluoroacetyl-L-lysine is a compound of considerable strategic importance. Its high purity, specific applications in pharmaceutical synthesis, and broad utility in organic chemistry solidify its position as an essential intermediate for companies at the forefront of scientific innovation.